Venclexta and Pioglitazone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Venclexta (venetoclax) and Pioglitazone (pioglitazone hydrochloride). Common drug interactions include asthenia among females and sepsis among males.

The phase IV clinical study analyzes what interactions people have when they take Venclexta and Pioglitazone. It is created by eHealthMe based on reports of 34 people who take the same drugs from the FDA, and is updated regularly.

What is Venclexta?

Venclexta has active ingredients of venetoclax. eHealthMe is studying from 31,425 Venclexta users. Check the latest studies of Venclexta.

What is Pioglitazone?

Pioglitazone has active ingredients of pioglitazone hydrochloride. It is often used in diabetes. eHealthMe is studying from 12,864 Pioglitazone users. Check the latest studies of Pioglitazone.

On Jul, 27, 2026

34 people who take Venclexta and Pioglitazone together, and have interactions are studied.

Venclexta and Pioglitazone drug interactions.

What are the common drug interactions of Venclexta and Pioglitazone, by gender? *:

female:

Asthenia (weakness)
Body temperature increased
Carbon dioxide increased
Infection
Pulmonary oedema (fluid accumulation in the lungs)
Granulocyte count decreased
Herpes zoster
High density lipoprotein decreased
Localised infection (infection at the single location)
Myalgia (muscle pain)

male:

Sepsis (a severe blood infection that can lead to organ failure and death)
Vomiting
Death
Disseminated intravascular coagulation (systemic activation of blood coagulation)
Febrile neutropenia (fever with reduced white blood cells)
Haemorrhage intracranial (bleeding within the skull)
Pain
Pleural effusion (water on the lungs)
Pneumonia fungal
Cellulitis (infection under the skin)

What are the common drug interactions of Venclexta and Pioglitazone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Death
Granulocyte count decreased
High density lipoprotein decreased
Myalgia (muscle pain)
Myelosuppression (a decrease in the production of blood cells)
White blood cell count decreased

60+:

Vomiting
Nausea (feeling of having an urge to vomit)
B-cell lymphoma (blood cancer affecting b cells)
Dysphagia (a condition in which swallowing is difficult or painful)
Non-hodgkin's lymphoma (malignant (cancer) cells form in the lymph system)
Vagus nerve paralysis
Asthenia (weakness)
Dyspnoea (difficult or laboured respiration)
Sepsis (a severe blood infection that can lead to organ failure and death)
Chest pain

What are the existing conditions these people have? *

Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 14 people, 41.18%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 11 people, 32.35%
Neuropathy Peripheral (surface nerve damage): 3 people, 8.82%
Type 2 Diabetes: 2 people, 5.88%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 2 people, 5.88%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 2 people, 5.88%
Mantle Cell Lymphoma (cancer of lymphocytes, a type of white blood cell): 2 people, 5.88%
Lymphocytic Leukaemia (a type of cancer in which the bone marrow makes too many lymphocytes): 2 people, 5.88%
Hypotension (abnormally low blood pressure): 2 people, 5.88%
High Blood Pressure: 2 people, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Venclexta and Pioglitazone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously